Core Points - Aimfinity Investment Corp. I (AIMA) will be delisted from Nasdaq and will begin trading on OTC Markets under new tickers on May 5, 2025 [1] - AIMA's business combination with Docter Inc. remains on track despite the venue change, with both parties committed to securing Nasdaq listing approval for the combined entity [2] - AIMA has extended the deadline to complete the business combination to May 28, 2025, by depositing $55,823.80 into its trust account [3][4] Company Information - Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) focused on merging with high-growth potential businesses [5] - Docter Inc. is a health technology company that develops innovative health monitoring solutions to improve global healthcare accessibility and efficiency [6] Transaction Details - AIMA entered into a merger agreement with Docter on October 13, 2023, involving a reincorporation merger and an acquisition merger [7] - The proxy statement/prospectus related to the proposed business combination has been mailed to AIMA's shareholders as of February 25, 2025 [12]

Company Overview - Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands, focused on effecting mergers, share exchanges, asset acquisitions, and similar business combinations with various businesses or entities [3] - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [3] - Aimfinity will not complete its initial business combination with any target headquartered in China or conducting a majority of its business in China [3] Business Combination Update - The company announced an extension of the deadline to complete its initial business combination from February 28, 2025, to March 28, 2025, with a Monthly Extension Payment of $55,823.8, equating to $0.05 per Class A ordinary share held by public shareholders [1][2] - This extension is the second of nine monthly extensions allowed under the company's current charter, which permits monthly extensions from January 28, 2025, until October 28, 2025 [2] Merger Agreement - On October 13, 2023, Aimfinity entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [4] - The press release indicates that further information regarding the proposed business combination will be provided in a proxy statement/prospectus to be mailed to stockholders [4]